Prosecution Insights
Last updated: April 19, 2026

Examiner: ADAMS, MICHELLE

Tech Center 1700 • Art Units: 1777 1797

This examiner grants 59% of resolved cases

Performance Statistics

58.6%
Allow Rate
-6.4% vs TC avg
584
Total Applications
+40.3%
Interview Lift
1399
Avg Prosecution Days
Based on 565 resolved cases, 2023–2026

Rejection Statute Breakdown

3.8%
§101 Eligibility
21.5%
§102 Novelty
29.3%
§103 Obviousness
35.8%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18470507 METHODS FOR QUANTIFYING DRUG CONCENTRATION IN A PRODRUG COMPOSITION Non-Final OA GENZYME CORPORATION
17960629 PHOTOACTIVATABLE VIBRATIONAL PROBES AND USES THEREOF Non-Final OA California Institute of Technology
17155298 SINGLE MOLECULE SEQUENCING IDENTIFICATION OF POST-TRANSLATIONAL MODIFICATIONS ON PROTEINS Non-Final OA Board of Regents, The University of Texas System
17732975 SENSOR AND METHOD FOR DETECTING HEAVY METALS USING CARBON NANOTUBES Final Rejection Morgan State University
18629129 SELECTIVE OPTICAL AQUEOUS AND NONAQUEOUS DETECTION OF FREE SULFITES Non-Final OA The Research Foundation for The State University of New York
17606759 METHODS AND REAGENTS FOR CLEAVAGE OF THE N-TERMINAL AMINO ACID FROM A POLYPEPTIDE Final Rejection Encodia, Inc.
17738399 Methods for Determining Equivalent Alkane Carbon Number Non-Final OA Colgate-Palmolive Company
17424265 ADVANCED METHODS FOR AUTOMATED HIGH-PERFORMANCE IDENTIFICATION OF CARBOHYDRATES AND CARBOHYDRATE MIXTURE COMPOSITION PATTERNS AND SYSTEMS THEREFORE AS WELL AS METHODS FOR CALIBRATION OF MULTI WAVELENGTH FLUORESCENCE DETECTION SYSTEMS THEREFORE, BASED ON NEW FLUORESCENT DYES Final Rejection MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V
17282747 USE OF A SUBSTITUTED OR UNSUBSTITUTED POLYCYCLIC AROMATIC HYDROCARBON COMPOUND FOR HIGH-RESOLUTION MICROSCOPY Non-Final OA Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V
17762664 FLUORESCENT PROBE AND APPLICATIONS THEREOF Non-Final OA HOSPICES CIVILS DE LYON
18432898 METHOD FOR ANALYZING BY-PRODUCTS OF RNA IN VITRO TRANSCRIPTION Non-Final OA CureVac Manufacturing GmbH
17769353 METHOD OF DIAGNOSING EARLY-STAGE NON-SMALL CELL LUNG CANCER Non-Final OA BIOMARK CANCER SYSTEMS INC.
17587940 MODEL FOR EVALUATING DEGREE OF LIVER FIBROSIS CONSTRUCTED BASED ON BILE ACIDS Non-Final OA Zhejiang Provincial People's Hospital

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month